Zhejiang Hisun Pharmaceutical Co., Ltd.

SHSE:600267 Voorraadrapport

Marktkapitalisatie: CN¥9.8b

Zhejiang Hisun Pharmaceutical Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kevin Xiao

Algemeen directeur

CN¥869.5k

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO1.1yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn5.5yrs
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Zhejiang Hisun Pharmaceutical Co., Ltd.'s (SHSE:600267) Shares Lagging The Industry But So Is The Business

Sep 26
Zhejiang Hisun Pharmaceutical Co., Ltd.'s (SHSE:600267) Shares Lagging The Industry But So Is The Business

These 4 Measures Indicate That Zhejiang Hisun Pharmaceutical (SHSE:600267) Is Using Debt Reasonably Well

Apr 30
These 4 Measures Indicate That Zhejiang Hisun Pharmaceutical (SHSE:600267) Is Using Debt Reasonably Well

Investors Don't See Light At End Of Zhejiang Hisun Pharmaceutical Co., Ltd.'s (SHSE:600267) Tunnel

Mar 29
Investors Don't See Light At End Of Zhejiang Hisun Pharmaceutical Co., Ltd.'s (SHSE:600267) Tunnel

CEO

Kevin Xiao (55 yo)

1.1yrs

Tenure

CN¥869,500

Compensatie

Mr. Weihong Xiao, also known as Kevin, has been Chief Executive Officer at Zhejiang Hisun Pharmaceutical Co., Ltd. since October 11, 2023. He served as Chief Operating Officer at 3SBio Inc. since March 201...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Weihong Xiao
Chief Executive Officer1.1yrsCN¥869.50kgeen gegevens
Hong Shun Jin
Senior Vice President5.5yrsCN¥1.13m0.018%
CN¥ 1.8m
Zhiqing Yang
Senior Vice President5.5yrsCN¥1.39m0.021%
CN¥ 2.1m
Jiaqiu Du
Director and Senior Vice President5.5yrsCN¥2.13m0.021%
CN¥ 2.1m
Xi Fei Shen
Secretary of the Board7.1yrsCN¥825.50k0.013%
CN¥ 1.3m

5.5yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 600267 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.5 jaar).